Fresenius Medical Care AG (Fresenius Medical Care AG) EV-to-EBITDA

: 6.39 (As of Today)

View and export this data going back to 2009. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Fresenius Medical Care AG's enterprise value is $22,116 Mil. Fresenius Medical Care AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $3,462 Mil. Therefore, Fresenius Medical Care AG's EV-to-EBITDA for today is 6.39.

The historical rank and industry rank for Fresenius Medical Care AG's EV-to-EBITDA or its related term are showing as below:

FMCQF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.18 Med: 9.22 Max: 12.87
Current: 6.51

During the past 13 years, the highest EV-to-EBITDA of Fresenius Medical Care AG was 12.87. The lowest was 6.18. And the median was 9.22.

FMCQF's EV-to-EBITDA is ranked better than
81.44% of 458 companies
in the Healthcare Providers & Services industry
Industry Median: 13.17 vs FMCQF: 6.51

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-16), Fresenius Medical Care AG's stock price is $36.95. Fresenius Medical Care AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.837. Therefore, Fresenius Medical Care AG's PE Ratio for today is 20.11.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Fresenius Medical Care AG EV-to-EBITDA Historical Data

The historical data trend for Fresenius Medical Care AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBITDA

8.56

7.80

8.38

6.49

7.12

Fresenius Medical Care AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA																6.49	7.44	7.66	7.76	7.12

Competitive Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius Medical Care AG EV-to-EBITDA Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's EV-to-EBITDA falls into.

Fresenius Medical Care AG EV-to-EBITDA Calculation

Fresenius Medical Care AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	22115.756	/	3461.55
	=	6.39

Fresenius Medical Care AG's current Enterprise Value is $22,116 Mil.
Fresenius Medical Care AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,462 Mil.

Fresenius Medical Care AG (OTCPK:FMCQF) EV-to-EBITDA Explanation

Fresenius Medical Care AG's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	36.95	/	1.837
	=	20.11

Fresenius Medical Care AG's share price for today is $36.95.
Fresenius Medical Care AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.837.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Fresenius Medical Care AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (OTCPK:FMCQF) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

FMS:USA FME:Italy FMEd:UK 0H9X:UK FME:Germany FMSC34:Brazil FME:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.freseniusmedicalcare.com

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.